Healius Upgraded To Neutral at JPMorgan
In a notable turn of events, JPMorgan has recently upgraded Healius shares (ASX: HLS), a prominent player in the diagnostics and research sector, from ‘Underweight’ to a ‘Neutral’ rating, adjusting the price target to $1.65 from the earlier $1. This adjustment comes after Healius successfully garnered an “impressive” price for its imaging business, a strategic…
Healius Limited (ASX: HLS)
Company Information Healius Limited (ASX: HLS) Healius Limited is a healthcare company. The Company’s segments include Pathology and Imaging. The Pathology segment is a provider of pathology services, including specialty pathology and clinical trials. The Imaging segment provides imaging services from standalone imaging sites, hospitals and medical centers. It has a network of…
18 Share Tips – 2nd October 2023
Elio D’Amato, Stockopedia BUY RECOMMENDATIONS BUY – Bendigo and Adelaide Bank (BEN) The bank was a standout in the recent earnings season.The company generates a solid return on equity and capital, and is cash flow positive. BEN also lifted earnings, improved its net interest margin, grew its customers and its dividend. Agribusiness and…
18 Share Tips – 18th September 2023
Toby Grimm, Baker Young BUY RECOMMENDATIONS BUY – ResMed Inc. (RMD) ResMed makes medical devices to treat sleep disordered breathing. The share price of RMD has significantly fallen since the company posted fourth quarter results in early August. Concerns about profit margins have overshadowed strong sales. Also, investors appear concerned that diabetes and…
18 Share Tips – 3rd April 2023
Peter Day, Sequoia Wealth Management BUY RECOMMENDATIONS Block Inc. (SQ2) The share price of this buy now, pay later provider can be rapidly volatile in either direction. On March 22, the shares closed at $115.15. On March 24, the stock closed at $88.94. The shares were trading at $99.28 on March 30. We view…
